 | Lantern Pharma Inc. | |||
| NCM : LTRN || Location: United States | ||||
$5.5+0.04 (+0.73%) |
0.13 M | 5.44 - 6.04 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.497 M |
| March 28, 2024 | 0.421 M |
| March 15, 2024 | 0.145 M |
| Feb. 29, 2024 | 0.068 M |
| Feb. 15, 2024 | 0.060 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.41 | -0.39 | 4.41% |
| 09/30/2023 | -0.46 | -0.29 | 37.51% |
| 06/30/2023 | -0.44 | -0.44 | 0.45% |
| 03/31/2023 | -0.49 | -0.36 | 26.47% |
| 12/31/2022 | -0.48 | -0.31 | 35.34% |
LTRN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 10.741M | Shares Float | 7.859M |
| Short Float | 0.497M | Market Cap | 58.65M |
| Institution ownership | 22.64% | Insider ownership | 15.059% |
| Earnings Date | 04/30/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.47 | Forward EPS | -1.88 |